Navigation Links
Dendreon Announces Presentation of Data at the American Association of Cancer Research Annual Meeting
Date:4/6/2011

SEATTLE, April 6, 2011 /PRNewswire/ -- Dendreon Corporation (Nasdaq: DNDN) today announced the following data presentations taking place at the American Association of Cancer Research (AACR) 102nd Annual Meeting 2011 in Orlando, Florida:

  • Wednesday, April 6, 2011, 8:00 a.m. - 12:00 p.m. ET.  "B lymphocytes are activated during the course of sipuleucel-T treatment, leading to an antigen-specific humoral response."  Poster presentation.
  • Wednesday, April 6, 2011, 8:00 a.m. - 12:00 p.m. ET.  "Evidence of T lymphocyte activation following sipuleucel-T treatment."  Poster presentation.

About Dendreon

Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development and commercialization of novel therapeutics.  The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy product candidates designed to stimulate an immune response.  Dendreon's first autologous cellular immunotherapy product, PROVENGE® (sipuleucel-T), was approved by the FDA in April 2010.  Dendreon is also developing an orally-available small molecule that targets TRPM8 that could be applicable to multiple types of cancer.  The Company is headquartered in Seattle, Washington and has manufacturing facilities in New Jersey, Georgia and California.  Dendreon is traded on the Nasdaq Global Market under the symbol DNDN.  For more information about the Company and its programs, visit http://www.dendreon.com/.


'/>"/>
SOURCE Dendreon Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Dendreon Announces Webcast Presentations at Upcoming Conferences
2. Dendreon Expands Launch of PROVENGE
3. Dendreon Announces Exercise and Closing of Overallotment Option
4. Dendreon Announces Offering of $500 Million Convertible Senior Notes Due 2016
5. Dendreon Announces Webcast Presentation at J.P. Morgan Healthcare Conference
6. Dendreon Announces Presentation of PROVENGE Data at the American Society of Hematology and the Society of Urologic Oncology Annual Meetings
7. Dendreon Announces Webcast Presentation at Credit Suisse 2010 Health Care Conference
8. Dendreon Reports Third Quarter 2010 Financial Results
9. Dendreon Announces Presentation of PROVENGE Data at the 25th International Society for Biological Therapy of Cancer Annual Meeting
10. Dendreon Statement on CMS National Coverage Analysis
11. Dendreon Announces Presentation of PROVENGE Data at the American Urological Association Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... MARLBOROUGH, Mass. , April 20, 2017 /PRNewswire/ ... company developing innovative therapeutics that address significant unmet ... new data from the Company,s consumer product development ... technology, at the Society for Investigative Dermatology (SID) ... is to advance and promote the sciences relevant ...
(Date:4/20/2017)... ZappRx, Inc ., a digital health company focused on modernizing ... closed $25 million in Series B funding led by Qiming ... Seattle that is part of a broader ... round included participation from SR One , who led ... (formerly Google Ventures). As part of the financing, Mark ...
(Date:4/20/2017)... 20, 2017 Eyevensys, a private ... non-viral gene expression technology that enables the safe, local, ... address a wide range of ophthalmic diseases, announces it ... products Regulatory Agency (MHRA) to advance its technology into ... ...
Breaking Medicine Technology:
(Date:4/21/2017)... IL (PRWEB) , ... April 21, 2017 , ... Chicago ... revolutionize the removal of osteoma. An osteoma is a benign bony lump located on ... the eye and can cause difficulties with sight and pain. Dr. Shah has discovered ...
(Date:4/21/2017)... Lake City, Colo. (PRWEB) , ... April 21, 2017 , ... ... launch of the Flex House, the next project in the company’s esteemed VISION House ... to help homeowners use exactly the amount of resources they need to live affordably ...
(Date:4/21/2017)... ... April 21, 2017 , ... The ... A Week of Addiction and Recovery Education, from April 24 to April 28, ... substance use disorders. , The mission of AWARE is to instill a ...
(Date:4/21/2017)... MD (PRWEB) , ... April ... ... accreditation organization promoting quality-based imaging practices, is seeking candidates to serve on ... for diagnostic imaging. , “RadSite’s ultimate mission is improving image quality ...
(Date:4/21/2017)... ... April 21, 2017 , ... Each year, everyone is urged to ... clean, plant trees and look forward to a better future. However, supporting the environment ... outdoors. Indoor air quality can be two to five times more polluted than outdoor ...
Breaking Medicine News(10 mins):